TNFα promoter polymorphism is a risk factor for susceptibility in hepatocellular carcinoma in Korean population

Kang Wook JungEunyoung HaGyeong Im YuSung Jin KimWoo Jin ChungByoung Kuk JangJung Jeung LeeDong Hoon ShinJae Seok Hwang
Dept. of Preventive Medicine (예방의학); Dept. of Biochemistry (생화학); Dept. of Internal Medicine (내과학); Dept. of Emergency Medicine (응급의학); Institute for Cancer Research (암연구소)
Issue Date
Clinical Chimica Acta, Vol.407(1-2) : 16-19, 2009
Background The underlying genetic factors for the development and progression of hepatocellular carcinoma (HCC) are largely unknown. TNFα is a well characterized inflammatory mediator and is implicated in the development of HCC. We investigated TNFα polymorphisms for association with HCC. Methods The study population consisted of 227 HCC patients and 365 age and sex matched Korean controls. TNFα polymorphisms (G-238A, C-857T, and C-863A) were genotyped using pyrosequencing analysis. TNFα levels in patients with HCC were determined by enzyme linked immunosorbent assay (ELISA). Logistic regression analysis was used to determine the association with HCC and haplotype was calculated using EH program. Results Of three TNFα polymorphisms investigated in our study, C-863A did not correlate with HCC. However, both G-238A and C-857T were found to be significantly associated with HCC. TNFα −238A allele was more frequent in HCC patients than in control [P = 0.012; odds ratio (OR), 1.89; 95% confidence interval (CI), 1.14–3.13]. TNFα −857T was significantly associated with HCC patients (P = 0.001; OR, 1.63; 95% CI, 1.21–2.19). Haplotype analysis revealed that the GTC haplotype (G-238A, C-857T, C-863A) was a risk marker for HCC (P = 0.0021). Serum TNFα level was significantly increased in HCC patients with CT + TT genotype for TNFα −857 (P = 0.018). Conclusion Our data imply that TNFα G-238A and C-857T, not C-863A, polymorphisms may confer different susceptibilities to the development of HCC with TNFα −238A and −857T alleles playing as risk factors. Keywords Hepatocellular carcinoma; Tumor necrosis factor; Polymorphism
Appears in Collections:
1. Journal Papers (연구논문) > 1. School of Medicine (의과대학) > Dept. of Emergency Medicine (응급의학)
1. Journal Papers (연구논문) > 1. School of Medicine (의과대학) > Dept. of Biochemistry (생화학)
1. Journal Papers (연구논문) > 1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
1. Journal Papers (연구논문) > 1. School of Medicine (의과대학) > Dept. of Preventive Medicine (예방의학)
1. Journal Papers (연구논문) > 3. Research Institutues (연구소) > Institute for Cancer Research (암연구소)
Keimyung Author(s)
이중정; 신동훈; 하은영; 정우진; 장병국; 황재석; 김성진
Full Text
File in this Item
 사서에게 요청하기
RIS (EndNote)
XLS (Excel)


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.